Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Change in Account Payables: 2020-2025

Historic Change in Account Payables for Molecular Partners Ag (MOLN) over the last 5 years, with Sep 2025 value amounting to -$338,239.

  • Molecular Partners Ag's Change in Account Payables rose 80.97% to -$338,239 in Q3 2025 from the same period last year, while for Sep 2025 it was $585,988, marking a year-over-year increase of 159.27%. This contributed to the annual value of $595,632 for FY2024, which is 165.88% up from last year.
  • Molecular Partners Ag's Change in Account Payables amounted to -$338,239 in Q3 2025, which was down 203.60% from $326,498 recorded in Q2 2025.
  • In the past 5 years, Molecular Partners Ag's Change in Account Payables ranged from a high of $5.2 million in Q2 2021 and a low of -$5.5 million during Q4 2022.
  • Over the past 3 years, Molecular Partners Ag's median Change in Account Payables value was $774.13 (recorded in 2025), while the average stood at -$37,688.
  • In the last 5 years, Molecular Partners Ag's Change in Account Payables plummeted by 407.97% in 2022 and then soared by 174.63% in 2024.
  • Molecular Partners Ag's Change in Account Payables (Quarterly) stood at $1.8 million in 2021, then crashed by 407.97% to -$5.5 million in 2022, then skyrocketed by 83.47% to -$915,352 in 2023, then skyrocketed by 165.22% to $596,955 in 2024, then spiked by 80.97% to -$338,239 in 2025.
  • Its Change in Account Payables was -$338,239 in Q3 2025, compared to $326,498 in Q2 2025 and $774.13 in Q1 2025.